IBDEI3J3 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2665,0)
 ;;=B DIAGNOSES^2^243
 ;;^UTILITY(U,$J,358.4,2666,0)
 ;;=G DIAGNOSES^7^243
 ;;^UTILITY(U,$J,358.4,2667,0)
 ;;=H DIAGNOSES^8^243
 ;;^UTILITY(U,$J,358.4,2668,0)
 ;;=L DIAGNOSES^11^243
 ;;^UTILITY(U,$J,358.4,2669,0)
 ;;=O DIAGNOSES^14^243
 ;;^UTILITY(U,$J,358.4,2670,0)
 ;;=U DIAGNOSES^19^243
 ;;^UTILITY(U,$J,358.4,2671,0)
 ;;=Z DIAGNOSES^23^243
 ;;^UTILITY(U,$J,358.4,2672,0)
 ;;=TELEHEALTH FACILITY FEE^1^244
 ;;^UTILITY(U,$J,358.4,2673,0)
 ;;=INFECTIOUS DISEASE^7^245
 ;;^UTILITY(U,$J,358.4,2674,0)
 ;;=NEOPLASMS^9^245
 ;;^UTILITY(U,$J,358.4,2675,0)
 ;;=HEMATOLOGY/ENDOCRINE^5^245
 ;;^UTILITY(U,$J,358.4,2676,0)
 ;;=MENTAL HEALTH^8^245
 ;;^UTILITY(U,$J,358.4,2677,0)
 ;;=NEUROLOGY^10^245
 ;;^UTILITY(U,$J,358.4,2678,0)
 ;;=OPHTHALMOLOGY^11^245
 ;;^UTILITY(U,$J,358.4,2679,0)
 ;;=GI^4^245
 ;;^UTILITY(U,$J,358.4,2680,0)
 ;;=CARDIOLOGY^1^245
 ;;^UTILITY(U,$J,358.4,2681,0)
 ;;=HERNIA^6^245
 ;;^UTILITY(U,$J,358.4,2682,0)
 ;;=GENITOURINARY^3^245
 ;;^UTILITY(U,$J,358.4,2683,0)
 ;;=SKIN^15^245
 ;;^UTILITY(U,$J,358.4,2684,0)
 ;;=ENT^2^245
 ;;^UTILITY(U,$J,358.4,2685,0)
 ;;=RHEUMATOLOGY/ORTHO^13^245
 ;;^UTILITY(U,$J,358.4,2686,0)
 ;;=RESPIRATORY^12^245
 ;;^UTILITY(U,$J,358.4,2687,0)
 ;;=SIGNS/SYMPTOMS/HX OF^14^245
 ;;^UTILITY(U,$J,358.4,2688,0)
 ;;=VASCULAR^16^245
 ;;^UTILITY(U,$J,358.4,2689,0)
 ;;=MD/NP/PA ^1^246
 ;;^UTILITY(U,$J,358.4,2690,0)
 ;;=RN/LPN/SW/OTH HC PROF^2^246
 ;;^UTILITY(U,$J,358.4,2691,0)
 ;;=TELEPHONE DIAGNOSES^1^247
 ;;^UTILITY(U,$J,358.4,2692,0)
 ;;=CHEST WALL AND NECK^1^248
 ;;^UTILITY(U,$J,358.4,2693,0)
 ;;=THORACIC^2^248
 ;;^UTILITY(U,$J,358.4,2694,0)
 ;;=OTHER PROCEDURES^3^248
 ;;^UTILITY(U,$J,358.4,2695,0)
 ;;=NEW PATIENT^2^249
 ;;^UTILITY(U,$J,358.4,2696,0)
 ;;=ESTABLISHED PATIENT^1^249
 ;;^UTILITY(U,$J,358.4,2697,0)
 ;;=CONSULTATIONS^3^249
 ;;^UTILITY(U,$J,358.4,2698,0)
 ;;=POST-OP FOLLOW-UP^4^249
 ;;^UTILITY(U,$J,358.4,2699,0)
 ;;=GENERAL SIGNS & SYMPTOMS^3^250
 ;;^UTILITY(U,$J,358.4,2700,0)
 ;;=AFTERCARE POST-OP^1^250
 ;;^UTILITY(U,$J,358.4,2701,0)
 ;;=POST-OP COMPLICATIONS^5^250
 ;;^UTILITY(U,$J,358.4,2702,0)
 ;;=CARDIOVASCULAR^2^250
 ;;^UTILITY(U,$J,358.4,2703,0)
 ;;=RESPIRATORY^7^250
 ;;^UTILITY(U,$J,358.4,2704,0)
 ;;=NEOPLASM^4^250
 ;;^UTILITY(U,$J,358.4,2705,0)
 ;;=PRE-OP^6^250
 ;;^UTILITY(U,$J,358.4,2706,0)
 ;;=NEW PATIENT^2^251
 ;;^UTILITY(U,$J,358.4,2707,0)
 ;;=ESTABLISHED PATIENT^1^251
 ;;^UTILITY(U,$J,358.4,2708,0)
 ;;=CONSULTATIONS^3^251
 ;;^UTILITY(U,$J,358.4,2709,0)
 ;;=POST OP VISIT (GLOBAL)^4^251
 ;;^UTILITY(U,$J,358.4,2710,0)
 ;;=BONE MARROW^1^252
 ;;^UTILITY(U,$J,358.4,2711,0)
 ;;=HEART^2^252
 ;;^UTILITY(U,$J,358.4,2712,0)
 ;;=HEART-LUNG^3^252
 ;;^UTILITY(U,$J,358.4,2713,0)
 ;;=LIVER^4^252
 ;;^UTILITY(U,$J,358.4,2714,0)
 ;;=LUNG^5^252
 ;;^UTILITY(U,$J,358.4,2715,0)
 ;;=PANCREAS^6^252
 ;;^UTILITY(U,$J,358.4,2716,0)
 ;;=RENAL^7^252
 ;;^UTILITY(U,$J,358.4,2717,0)
 ;;=REPAIR/RESECTION OF DONOR HEART^8^252
 ;;^UTILITY(U,$J,358.4,2718,0)
 ;;=CHRONIC PULM. HEART DISEASE^1^253
 ;;^UTILITY(U,$J,358.4,2719,0)
 ;;=DIS. OF BLOOD/FORMING ORGA^3^253
 ;;^UTILITY(U,$J,358.4,2720,0)
 ;;=HERNIA^5^253
 ;;^UTILITY(U,$J,358.4,2721,0)
 ;;=KIDNEY/PANCREAS^6^253
 ;;^UTILITY(U,$J,358.4,2722,0)
 ;;=LIVER^7^253
 ;;^UTILITY(U,$J,358.4,2723,0)
 ;;=LUNG^8^253
 ;;^UTILITY(U,$J,358.4,2724,0)
 ;;=MALIGNANT LYMPH & HEMATOP^9^253
 ;;^UTILITY(U,$J,358.4,2725,0)
 ;;=MALIGNANT NEOPLASMS SOLID ORGANS^10^253
 ;;^UTILITY(U,$J,358.4,2726,0)
 ;;=METABOLIC DISORDERS^11^253
 ;;^UTILITY(U,$J,358.4,2727,0)
 ;;=SYMPTOMS/SIGNS^12^253
 ;;^UTILITY(U,$J,358.4,2728,0)
 ;;=COMPLICATIONS OF SURGERY^2^253
